| CASE REPORT |
|
| Year : 2023 | Volume
: 3
| Issue : 2 | Page : 402-404 |
|
|
Successful management of rubella retinopathy–related subretinal neovascular membrane with intravitreal ranibizumab: A case report
Amrita Dey1, Bristi Majumdar1, Ahana Sen1, Sukanya Gorhe1, Manpreet Chugh1, Kumar Saurabh2, Rupak Roy1
1 Department of Vitreo Retina, Aditya Birla Sankara Nethralaya, Kolkata, West Bengal, India
2 Department of Vitreo Retina, Nethralayam Superspeciality Eye Hospital, Kolkata, West Bengal, India
Correspondence Address:
Rupak Roy
Aditya Birla Sankara Nethralaya, 147, Mukundapur, E.M. Bypass, Kolkata - 700 099, West Bengal
India
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/ijo.IJO_1728_22
|
|
|
A seven-year-old boy with a known case of bilateral rubella retinopathy presented to us as part of his annual follow-up. Best-corrected visual acuity (BCVA) at presentation was 20/80 in the right eye and 20/600 in the left eye. On dilated fundoscopy, the right eye showed the presence of subretinal neovascular membrane (SRNVM), subretinal fluid, and classical salt-and-pepper retinopathy, all of which was documented by imaging. The left eye was poorly dilating and showed a pale disc. The right eye was treated with two doses of intravitreal ranibizumab at an interval of two months. Post-treatment examination showed resolution of SRNVM accompanied by scarring and significant improvement in BCVA.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
